A PHASE II TRIAL OF COMBINED LUTETIUM-PSMA THERANOSTICS AND DOCETAXEL IN NEWLY DIAGNOSED METASTATIC HORMONENAÏVE PROSTATE CANCER

Grant number: W81XWH1910651 001 1332566 | Funding period: 2019 - 2022

Active

Researchers